Allan G. Redeker, M.D.
This content is PDF only. Please click on the PDF icon to access.
Erythropoietic protoporphyria, a new medical syndrome first described in 1961, is a familial, photocutaneous disorder, inherited as a Mendelian dominant. The hallmark of the disease is a marked increase in the erythrocyte protoporphyrin content. The fecal protoporphyrin excretion is similarly increased, but protoporphyrin does not appear in the urine. The photosensitivity is due to protoporphyrin circulating in the plasma. The source of the plasma porphyrin may be either hepatic or erythropoietic or both. In some families, asymptomatic individuals with increased erythrocyte protoporphyrin values but no porphyrin in the plasma have been observed. Photosensitivity begins early in childhood and may present
Redeker AG. Erythropoietic Protoporphyria: A New Clinical Syndrome.. Ann Intern Med. ;61:811. doi: 10.7326/0003-4819-61-4-811_1
Download citation file:
Published: Ann Intern Med. 1964;61(4):811.
Gastroenterology/Hepatology, Liver Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use